Estimation of Erosion Danger Lands of the Reclamation Fund in Georgia

Erosion danger of lands of the reclamation fund in Georgia was studied by means of the Universal Soil Loss Equation (USLE) (Wischmeier and Smith, 1978), which was modified in the Problem Lab of Soil Erosion and River Bed Processes of Moscow State University (Anonymous, 1982). By the investigation was established that average annual potential soil loss, which was counted by means of USLE, is 10,5 % less than real loss of soil. If for the calculation of the potential soil loss we use only rains which provoke soil erosion, the difference between real and counted soil losses is only 1.77 % i.e. exactness of soil erosion forecast increases 5-6 times

Global Journalist: Siege on Moscow amid global terrorism crisis

Global Journalist, October 31, 2002 show: On October 31, 2002, Chechen terrorist rebels sieged a theatre in Moscow taking hundreds of occupants hostage. Byron Scott discusses the media coverage of the Moscow theatre hostage crisis with Russian journalists and UN media correspondents. Amid the global rise of terrorism, Global Journalist raises concerns for media ethics and press freedom as tension increases between Chechnya and the Russian Federation. Host: Byron Scott. Guests: Akaki Gogichaishvili, Betsy Pisik, Alexander Merkushev, Andrei Zolotov. Producers: Sarah Fajardo. Directors: Pat Akers

Radon Concentration in Water on the Several Regions of Georgia

Quantitative assessment of radon distribution in Georgia has been carried out. According to field data, assessment background value of Radon in water from the surface, shallow and deep layer

Indoor Radon Concentrations in Selected Buildings of Georgia

Within the project “Radon mapping and radon risk assessment in Georgia”, funded by the Shota Rustaveli National Science Foundation of Georgia in 2019‒2022 (SRNSFG FN-19-22022), systematic radon (222Rn, Rn) surveys in indoor air, soil gas, and waters were carried out in Georgia. The indoor radon study included 702 locations in 11 administrative regions of Georgia. Altogether, 1338 rooms in 107 schools, 540 kindergartens, 6 city halls, and 57 homes were examined for radon all year round by exposing solid-state nuclear track detectors RSFV from Radosys Ltd. Rn concentrations ranged from 2 to 1226 Bq m3, with an annual arithmetic mean value of 84 Bq m3 for all the regions. The annual effective doses ranged from 0.2 to 3.8 mSv with an arithmetic mean value of 1.2 mSv a1

The first meeting of the European Register of Cystic Echinococcosis (ERCE)

Cystic echinococcosis (CE) is a zoonotic parasitic disease endemic in southern and eastern European countries. The true prevalence of CE is difficult to estimate due to the high proportion of asymptomatic carriers who never seek medical attention and to the underreporting of diagnosed cases, factors which contribute to its neglected status. In an attempt to improve this situation, the European Register of Cystic Echinococcosis (ERCE), was launched in October 2014 in the context of the HERACLES project. ERCE is a prospective, observational, multicentre register of patients with probable or confirmed CE. The first ERCE meeting was held in November 2015 at the Italian National Institute of Health (Istituto Superiore di Sanita, ISS) in Rome, to bring together CE experts currently involved in the Register activities, to share and discuss experiences, and future developments.Although the Register is still in its infancy, data collected at the time of writing this report, had outnumbered the total of national cases reported by the European endemic countries and published by the European Centre for Disease Prevention and Control in 2015. This confirms the need for an improved reporting system of CE at the European level. The collection of standardized clinical data and samples is expected to support a more rational, stage-specific approach to clinical management, and to help public authorities harmonize reporting of CE. A better understanding of CE burden in Europe will encourage the planning and implementation of public health policies toward its control

The First Meeting of the European Register of Cystic Echinococcosis (Erce)

Cystic echinococcosis (CE) is a zoonotic parasitic disease endemic in southern and eastern European countries. The true prevalence of CE is difficult to estimate due to the high proportion of asymptomatic carriers who never seek medical attention and to the underreporting of diagnosed cases, factors which contribute to its neglected status. In an attempt to improve this situation, the European Register of Cystic Echinococcosis (ERCE), was launched in October 2014 in the context of the HERACLES project. ERCE is a prospective, observational, multicentre register of patients with probable or confirmed CE. The first ERCE meeting was held in November 2015 at the Italian National Institute of Health (Istituto Superiore di Sanita, ISS) in Rome, to bring together CE experts currently involved in the Register activities, to share and discuss experiences, and future developments., Although the Register is still in its infancy, data collected at the time of writing this report, had outnumbered the total of national cases reported by the European endemic countries and published by the European Centre for Disease Prevention and Control in 2015. This confirms the need for an improved reporting system of CE at the European level. The collection of standardized clinical data and samples is expected to support a more rational, stage-specific approach to clinical management, and to help public authorities harmonize reporting of CE. A better understanding of CE burden in Europe will encourage the planning and implementation of public health policies toward its control.PubMedWoSScopu

Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial

Background: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. Methods: The CRASH-3 trial randomised 9202 patients within 3 h of injury with a GCS score ≤ 12 or intracranial bleeding on CT scan and no significant extracranial bleeding to receive TXA or placebo. We conducted an exploratory analysis of the effects of TXA on all-cause mortality within 24 h of injury and within 28 days, excluding patients with a GCS score of 3 or bilateral unreactive pupils, stratified by severity and country income. We pool data from the CRASH-2 and CRASH-3 trials in a one-step fixed effects individual patient data meta-analysis. Results: There were 7637 patients for analysis after excluding patients with a GCS score of 3 or bilateral unreactive pupils. Of 1112 deaths, 23.3% were within 24 h of injury (early deaths). The risk of early death was reduced with TXA (112 (2.9%) TXA group vs 147 (3.9%) placebo group; risk ratio [RR] RR 0.74, 95% CI 0.58–0.94). There was no evidence of heterogeneity by severity (p = 0.64) or country income (p = 0.68). The risk of death beyond 24 h of injury was similar in the TXA and placebo groups (432 (11.5%) TXA group vs 421 (11.7%) placebo group; RR 0.98, 95% CI 0.69–1.12). The risk of death at 28 days was 14.0% in the TXA group versus 15.1% in the placebo group (544 vs 568 events; RR 0.93, 95% CI 0.83–1.03). When the CRASH-2 and CRASH-3 trial data were pooled, TXA reduced early death (RR 0.78, 95% CI 0.70–0.87) and death within 28 days (RR 0.88, 95% CI 0.82–0.94). Conclusions: Tranexamic acid reduces early deaths in non-moribund TBI patients regardless of TBI severity or country income. The effect of tranexamic acid in patients with isolated TBI is similar to that in polytrauma. Treatment is safe and even severely injured patients appear to benefit when treated soon after injury. Trial registration: ISRCTN15088122, registered on 19 July 2011; NCT01402882, registered on 26 July 2011